Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Oncorus, Inc.

Oncorus Announces Workforce Reduction Plan
From Oncorus, Inc.
Via GlobeNewswire
Tickers ONCR
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
From Oncorus, Inc.
Via GlobeNewswire
Tickers ONCR
Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
From Oncorus, Inc.
Via GlobeNewswire
Tickers ONCR
Oncorus Announces Research Collaboration with Daewoong Pharmaceutical for the Development of Lipid Nanoparticle Formulations for mRNA Drug Candidates
From Oncorus, Inc.
Via GlobeNewswire
Tickers ONCR
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
From Oncorus, Inc.
Via GlobeNewswire
Tickers ONCR
Oncorus to Participate in Upcoming Investor Conferences
From Oncorus, Inc.
Via GlobeNewswire
Tickers ONCR
Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual Meeting
From Oncorus, Inc.
Via GlobeNewswire
Tickers ONCR
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
From Oncorus, Inc.
Via GlobeNewswire
Tickers ONCR
Oncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of Cancer
From Oncorus, Inc.
Via GlobeNewswire
Tickers ONCR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.